Paper25354682
Tumor-specific suicide gene therapy for hepatocellular carcinoma by transcriptionally targeted retroviral replicating vectors.
Lai YH and 3 others. Gene Ther, 2015. Cited by 13 papers, by iCite.
Cite this record
ConductScience Library. Tumor-specific suicide gene therapy for hepatocellular carcinoma by transcriptionally targeted retroviral replicating vectors. Papers, record 25354682. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/25354682
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Tumor-specific suicide gene therapy for hepatocellular carcinoma by transcriptionally targeted retroviral replicating vectors.
- PubMed
Topics22
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Carcinoma, Hepatocellular | Major topic |
| Leukemia Virus, Murine | Major topic |
| Liver Neoplasms, Experimental | Major topic |
| Animals | |
| Base Sequence | |
| Genetic Therapy | |
| Genetic Vectors | |
| Genomic Instability | |
| Green Fluorescent Proteins | |
| HEK293 Cells | |
| Hep G2 Cells | |
| Humans | |
| MCF-7 Cells | |
| Mice, Inbred BALB C | |
| Mice, Nude | |
| Molecular Sequence Data | |
| Neoplasm Transplantation | |
| Promoter Regions, Genetic | |
| Terminal Repeat Sequences | |
| Transcription, Genetic | |
| Virus Replication | |
| alpha-Fetoproteins |
Source PubMed
References45
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 9396605 | Therapy of malignant brain tumors by intratumoral implantation of retroviral vector-producing cells. | Nat Med | 1997 | https://conductscience.org/library/papers/9396605 | PubMed |
| 2 | 9634004 | Metabolism and metabolic actions of 6-methylpurine and 2-fluoroadenine in human cells. | Biochem Pharmacol | 1998 | https://conductscience.org/library/papers/9634004 | PubMed |
| 3 | 1838933 | Evaluation of lymphoid-specific enhancer addition or substitution in a basic retrovirus vector. | Hum Gene Ther | 1991 | https://conductscience.org/library/papers/1838933 | PubMed |
| 4 | 18509380 | Cell entry targeting restricts biodistribution of replication-competent retroviruses to tumour tissue. | Gene Ther | 2008 | https://conductscience.org/library/papers/18509380 | PubMed |
| 5 | 9080121 | Purified herpes simplex thymidine kinase Retrovector particles. I. In vitro characterization, in situ transduction efficiency, and histopathological analyses of gene therapy-treated brain tumors. | Cancer Gene Ther | 1997 | https://conductscience.org/library/papers/9080121 | PubMed |
| 6 | 12728277 | Progress and problems with the use of viral vectors for gene therapy. | Nat Rev Genet | 2003 | https://conductscience.org/library/papers/12728277 | PubMed |
| 7 | 24825189 | MicroRNA 142-3p attenuates spread of replicating retroviral vector in hematopoietic lineage-derived cells while maintaining an antiviral immune response. | Hum Gene Ther | 2014 | https://conductscience.org/library/papers/24825189 | PubMed |
| 8 | 7645245 | Effects of adoptive immune transfers on murine leukemia virus-infection of rats. | Virology | 1995 | https://conductscience.org/library/papers/7645245 | PubMed |
| 9 | 1317968 | In vivo gene transfer with retroviral vector-producer cells for treatment of experimental brain tumors. | Science | 1992 | https://conductscience.org/library/papers/1317968 | PubMed |
| 10 | 2370865 | Gene transfer by retrovirus vectors occurs only in cells that are actively replicating at the time of infection. | Mol Cell Biol | 1990 | https://conductscience.org/library/papers/2370865 | PubMed |
| 11 | 11096443 | A phase III clinical evaluation of herpes simplex virus type 1 thymidine kinase and ganciclovir gene therapy as an adjuvant to surgical resection and radiation in adults with previously untreated glioblastoma multiforme. | Hum Gene Ther | 2000 | https://conductscience.org/library/papers/11096443 | PubMed |
| 12 | 20467451 | Enhanced efficiency of prodrug activation therapy by tumor-selective replicating retrovirus vectors armed with the Escherichia coli purine nucleoside phosphorylase gene. | Cancer Gene Ther | 2010 | https://conductscience.org/library/papers/20467451 | PubMed |
| 13 | 1699279 | Pharmacokinetics of 2-F-ara-A (9-beta-D-arabinofuranosyl-2-fluoroadenine) in cancer patients during the phase I clinical investigation of fludarabine phosphate. | Semin Oncol | 1990 | https://conductscience.org/library/papers/1699279 | PubMed |
| 14 | 15374975 | Excellent in vivo bystander activity of fludarabine phosphate against human glioma xenografts that express the escherichia coli purine nucleoside phosphorylase gene. | Cancer Res | 2004 | https://conductscience.org/library/papers/15374975 | PubMed |
| 15 | 2427240 | Pharmacokinetic study of fludarabine phosphate (NSC 312887). | Cancer Chemother Pharmacol | 1986 | https://conductscience.org/library/papers/2427240 | PubMed |
| 16 | 9195219 | Establishment of parameters for optimal transduction efficiency and antitumor effects with purified high-titer HSV-TK retroviral vector in established solid tumors. | Hum Gene Ther | 1997 | https://conductscience.org/library/papers/9195219 | PubMed |
| 17 | 11435579 | Genomic stability of murine leukemia viruses containing insertions at the Env-3' untranslated region boundary. | J Virol | 2001 | https://conductscience.org/library/papers/11435579 | PubMed |
| 18 | 17981778 | Replication-competent retrovirus vectors for cancer gene therapy. | Front Biosci | 2008 | https://conductscience.org/library/papers/17981778 | PubMed |
| 19 | 3031469 | Analysis of mutation in human cells by using an Epstein-Barr virus shuttle system. | Mol Cell Biol | 1987 | https://conductscience.org/library/papers/3031469 | PubMed |
| 20 | 9824049 | Retrovirus-mediated gene therapy for hepatocellular carcinoma: selective and enhanced suicide gene expression regulated by human alpha-fetoprotein enhancer directly linked to its promoter. | Cancer Gene Ther | 1998 | https://conductscience.org/library/papers/9824049 | PubMed |
Cited by8
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 13 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42325780 | Serum alpha-fetoprotein kinetics as a mechanistic biomarker for rAAV-TK/GCV efficacy in hepatocellular carcinoma. | Am J Transl Res | 2026 | https://conductscience.org/library/papers/42325780 | PubMed |
| 32085552 | Effect of Diphtheria Toxin-Based Gene Therapy for Hepatocellular Carcinoma. | Cancers (Basel) | 2020 | https://conductscience.org/library/papers/32085552 | PubMed |
| 31769427 | Gene Therapy for Liver Cancers: Current Status from Basic to Clinics. | Cancers (Basel) | 2019 | https://conductscience.org/library/papers/31769427 | PubMed |
| 30160343 | H1/pAIM2 nanoparticles exert anti-tumour effects that is associated with the inflammasome activation in renal carcinoma. | J Cell Mol Med | 2018 | https://conductscience.org/library/papers/30160343 | PubMed |
| 29563582 | Evaluation of the Glypican 3 promoter for transcriptional targeting of hepatocellular carcinoma. | Gene Ther | 2018 | https://conductscience.org/library/papers/29563582 | PubMed |
| 27843535 | Insights for hepatitis C virus related hepatocellular carcinoma genetic biomarkers: Early diagnosis and therapeutic intervention. | World J Hepatol | 2016 | https://conductscience.org/library/papers/27843535 | PubMed |
| 26648599 | Tissue Specific Promoters in Colorectal Cancer. | Dis Markers | 2015 | https://conductscience.org/library/papers/26648599 | PubMed |
| 26077653 | Management strategies for hepatocellular carcinoma: old certainties and new realities. | Clin Exp Med | 2016 | https://conductscience.org/library/papers/26077653 | PubMed |
Genes2
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| AFP | 174 | PubTator's text mining | https://conductscience.org/library/genes/174 | NCBI Gene |
| AP2B1 | 163 | PubTator's text mining | https://conductscience.org/library/genes/163 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/25354682
GET https://conductscience.org/api/papers/v1/25354682/references?page=2